Categories AlphaGraphs, Earnings, LATEST, Other Industries
Fastenal sees a dip despite beating Q3 estimates
Fastenal Company (FAST) topped market expectations on sales and profits for the third quarter of 2018 but shares still dropped over 2.5% during premarket hours on Wednesday.
The industrial supplies manufacturer reported net sales of $1.28 billion, up 13% from the same period last year, driven by higher unit sales and product pricing. Daily sales of fastener products rose 10.8% and for non-fastener products, the growth was 14.9%.
Net income grew 38% to $197.6 million or $0.69 per share from the prior-year period. The quarterly EPS benefited from discrete tax items and a lower tax rate during the quarter.
The company’s gross profit percentage dropped 100 basis points to 48.1% due to the impact of customer and product mix as well as higher freight costs at the branch level.
In a separate release, Fastenal reported a 7.8% increase in net sales for the month of September to $400 million. The company had reported monthly net sales growth of 17.6% and 13.7% for July and August respectively.
Fastenal signed 5,877 industrial vending devices during the quarter, up 23.2% from the same period last year and the company’s installed device count increased 14%. New national account contracts signed during the quarter totaled 41 and daily sales to national account customers grew 18% in the quarter versus last year.
Fastenal returned $367.9 million to shareholders in the first nine months of 2018 in the form of dividends and share repurchases compared to $359.7 million in the prior-year period.
Earnings Preview: Fastenal likely to beat Q3 results on strong demand
Most Popular
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company
Walgreens Boots Alliance set to report earnings next week. Here’s what to expect
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with